��������

Zach Scheiner is a Principal on the Investment Team at RA Capital Management. Zach works on both public and private investments and serves as a Board Director for Adagio Medical, Exo Imaging, LENZ Therapeutics, and Nkarta Therapeutics. Zach holds a BS in Molecular Biophysics and Biochemistry from Yale University, and a PhD in Neurobiology and Behavior from the University of Washington. Zach previously worked as a Science Officer at the California Institute for Regenerative Medicine.